- Clinical and translational research in lymphoma, with a focus on stem cell transplantation and development of novel therapies, as well as late effects of treatment
- Applied molecular oncology
R Michael Crump
Lancet Oncol. 2017 Feb 22;:
The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation options.
Support Care Cancer. 2017 Feb 02;:
J Clin Oncol. 2016 Jan 20;34(3_suppl):199
Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the Phase III CCTG LY.12 Trial.
Ann Oncol. 2016 Dec 19;:
J Natl Cancer Inst. 2016 Dec;108(12):
Hematol Oncol Clin North Am. 2016 Dec;30(6):1195-1213
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group.
Leuk Lymphoma. 2016 Oct 17;:1-8
Clin Oncol (R Coll Radiol). 2016 Sep 30;:
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.
Leuk Lymphoma. 2016 Jun 24;:1-10
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre